nodes	percent_of_prediction	percent_of_DWPC	metapath
Itraconazole—CYP1A1—Dacarbazine—muscle cancer	0.153	0.188	CbGbCtD
Itraconazole—CYP2E1—Dacarbazine—muscle cancer	0.118	0.146	CbGbCtD
Itraconazole—CYP3A7—Vincristine—muscle cancer	0.0655	0.0805	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0655	0.0805	CbGbCtD
Itraconazole—CYP2E1—Etoposide—muscle cancer	0.0579	0.0712	CbGbCtD
Itraconazole—ABCB1—Dactinomycin—muscle cancer	0.0519	0.0638	CbGbCtD
Itraconazole—CYP3A5—Vincristine—muscle cancer	0.0491	0.0604	CbGbCtD
Itraconazole—CYP3A5—Etoposide—muscle cancer	0.045	0.0553	CbGbCtD
Itraconazole—CYP2B6—Doxorubicin—muscle cancer	0.039	0.0479	CbGbCtD
Itraconazole—ABCB1—Vincristine—muscle cancer	0.032	0.0393	CbGbCtD
Itraconazole—ABCB1—Etoposide—muscle cancer	0.0293	0.036	CbGbCtD
Itraconazole—ABCB1—Doxorubicin—muscle cancer	0.02	0.0246	CbGbCtD
Itraconazole—ABCB1—Methotrexate—muscle cancer	0.0194	0.0238	CbGbCtD
Itraconazole—CYP3A4—Vincristine—muscle cancer	0.0192	0.0235	CbGbCtD
Itraconazole—CYP2D6—Doxorubicin—muscle cancer	0.0188	0.0231	CbGbCtD
Itraconazole—CYP3A4—Etoposide—muscle cancer	0.0176	0.0216	CbGbCtD
Itraconazole—CYP3A4—Doxorubicin—muscle cancer	0.012	0.0147	CbGbCtD
Itraconazole—Gastrointestinal disorder—Vincristine—muscle cancer	0.000355	0.00191	CcSEcCtD
Itraconazole—Fatigue—Vincristine—muscle cancer	0.000355	0.0019	CcSEcCtD
Itraconazole—Hypertension—Etoposide—muscle cancer	0.000352	0.00189	CcSEcCtD
Itraconazole—Constipation—Vincristine—muscle cancer	0.000352	0.00189	CcSEcCtD
Itraconazole—Pain—Vincristine—muscle cancer	0.000352	0.00189	CcSEcCtD
Itraconazole—Diplopia—Doxorubicin—muscle cancer	0.000352	0.00189	CcSEcCtD
Itraconazole—Chest pain—Etoposide—muscle cancer	0.000348	0.00187	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000345	0.00185	CcSEcCtD
Itraconazole—Pancreatitis—Methotrexate—muscle cancer	0.000344	0.00185	CcSEcCtD
Itraconazole—Discomfort—Etoposide—muscle cancer	0.000343	0.00184	CcSEcCtD
Itraconazole—Face oedema—Doxorubicin—muscle cancer	0.000339	0.00182	CcSEcCtD
Itraconazole—Hypersensitivity—Dactinomycin—muscle cancer	0.000339	0.00182	CcSEcCtD
Itraconazole—Abdominal discomfort—Methotrexate—muscle cancer	0.000336	0.00181	CcSEcCtD
Itraconazole—Gastrointestinal pain—Vincristine—muscle cancer	0.000336	0.0018	CcSEcCtD
Itraconazole—Confusional state—Etoposide—muscle cancer	0.000336	0.0018	CcSEcCtD
Itraconazole—Anaphylactic shock—Etoposide—muscle cancer	0.000333	0.00179	CcSEcCtD
Itraconazole—Infection—Etoposide—muscle cancer	0.000331	0.00178	CcSEcCtD
Itraconazole—Asthenia—Dactinomycin—muscle cancer	0.00033	0.00177	CcSEcCtD
Itraconazole—Blood creatinine increased—Doxorubicin—muscle cancer	0.000329	0.00177	CcSEcCtD
Itraconazole—Neutropenia—Methotrexate—muscle cancer	0.000328	0.00176	CcSEcCtD
Itraconazole—Dehydration—Doxorubicin—muscle cancer	0.000327	0.00175	CcSEcCtD
Itraconazole—Thrombocytopenia—Etoposide—muscle cancer	0.000326	0.00175	CcSEcCtD
Itraconazole—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000326	0.00175	CcSEcCtD
Itraconazole—Tachycardia—Etoposide—muscle cancer	0.000325	0.00175	CcSEcCtD
Itraconazole—Abdominal pain—Vincristine—muscle cancer	0.000325	0.00174	CcSEcCtD
Itraconazole—Body temperature increased—Vincristine—muscle cancer	0.000325	0.00174	CcSEcCtD
Itraconazole—Liver function test abnormal—Doxorubicin—muscle cancer	0.000325	0.00174	CcSEcCtD
Itraconazole—Skin disorder—Etoposide—muscle cancer	0.000324	0.00174	CcSEcCtD
Itraconazole—Erectile dysfunction—Methotrexate—muscle cancer	0.000323	0.00173	CcSEcCtD
Itraconazole—Hyperhidrosis—Etoposide—muscle cancer	0.000322	0.00173	CcSEcCtD
Itraconazole—Abdominal pain upper—Doxorubicin—muscle cancer	0.000321	0.00172	CcSEcCtD
Itraconazole—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000321	0.00172	CcSEcCtD
Itraconazole—Photosensitivity reaction—Methotrexate—muscle cancer	0.00032	0.00172	CcSEcCtD
Itraconazole—Hypokalaemia—Doxorubicin—muscle cancer	0.00032	0.00172	CcSEcCtD
Itraconazole—Breast disorder—Doxorubicin—muscle cancer	0.000318	0.00171	CcSEcCtD
Itraconazole—Anorexia—Etoposide—muscle cancer	0.000318	0.0017	CcSEcCtD
Itraconazole—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000317	0.0017	CcSEcCtD
Itraconazole—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000317	0.0017	CcSEcCtD
Itraconazole—Diarrhoea—Dactinomycin—muscle cancer	0.000315	0.00169	CcSEcCtD
Itraconazole—Pneumonia—Methotrexate—muscle cancer	0.000315	0.00169	CcSEcCtD
Itraconazole—Infestation NOS—Methotrexate—muscle cancer	0.000313	0.00168	CcSEcCtD
Itraconazole—Infestation—Methotrexate—muscle cancer	0.000313	0.00168	CcSEcCtD
Itraconazole—Drowsiness—Methotrexate—muscle cancer	0.000313	0.00168	CcSEcCtD
Itraconazole—Depression—Methotrexate—muscle cancer	0.000312	0.00167	CcSEcCtD
Itraconazole—Hypotension—Etoposide—muscle cancer	0.000311	0.00167	CcSEcCtD
Itraconazole—Gastritis—Doxorubicin—muscle cancer	0.000311	0.00167	CcSEcCtD
Itraconazole—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00031	0.00166	CcSEcCtD
Itraconazole—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00031	0.00166	CcSEcCtD
Itraconazole—Renal failure—Methotrexate—muscle cancer	0.000308	0.00165	CcSEcCtD
Itraconazole—Abdominal distension—Doxorubicin—muscle cancer	0.000306	0.00164	CcSEcCtD
Itraconazole—Dysphagia—Doxorubicin—muscle cancer	0.000304	0.00163	CcSEcCtD
Itraconazole—Hypersensitivity—Vincristine—muscle cancer	0.000303	0.00163	CcSEcCtD
Itraconazole—Paraesthesia—Etoposide—muscle cancer	0.000299	0.00161	CcSEcCtD
Itraconazole—Haematuria—Methotrexate—muscle cancer	0.000298	0.0016	CcSEcCtD
Itraconazole—Pancreatitis—Doxorubicin—muscle cancer	0.000298	0.0016	CcSEcCtD
Itraconazole—Dyspnoea—Etoposide—muscle cancer	0.000297	0.00159	CcSEcCtD
Itraconazole—Somnolence—Etoposide—muscle cancer	0.000296	0.00159	CcSEcCtD
Itraconazole—Hepatobiliary disease—Methotrexate—muscle cancer	0.000296	0.00159	CcSEcCtD
Itraconazole—Asthenia—Vincristine—muscle cancer	0.000295	0.00158	CcSEcCtD
Itraconazole—Vomiting—Dactinomycin—muscle cancer	0.000293	0.00157	CcSEcCtD
Itraconazole—Bronchitis—Doxorubicin—muscle cancer	0.000292	0.00157	CcSEcCtD
Itraconazole—Agranulocytosis—Methotrexate—muscle cancer	0.000292	0.00157	CcSEcCtD
Itraconazole—Rash—Dactinomycin—muscle cancer	0.00029	0.00156	CcSEcCtD
Itraconazole—Decreased appetite—Etoposide—muscle cancer	0.00029	0.00155	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Etoposide—muscle cancer	0.000288	0.00154	CcSEcCtD
Itraconazole—Fatigue—Etoposide—muscle cancer	0.000287	0.00154	CcSEcCtD
Itraconazole—Pain—Etoposide—muscle cancer	0.000285	0.00153	CcSEcCtD
Itraconazole—Constipation—Etoposide—muscle cancer	0.000285	0.00153	CcSEcCtD
Itraconazole—Neutropenia—Doxorubicin—muscle cancer	0.000284	0.00152	CcSEcCtD
Itraconazole—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000282	0.00152	CcSEcCtD
Itraconazole—Diarrhoea—Vincristine—muscle cancer	0.000281	0.00151	CcSEcCtD
Itraconazole—Hepatitis—Methotrexate—muscle cancer	0.000281	0.00151	CcSEcCtD
Itraconazole—Pollakiuria—Doxorubicin—muscle cancer	0.000281	0.00151	CcSEcCtD
Itraconazole—Pharyngitis—Methotrexate—muscle cancer	0.000279	0.0015	CcSEcCtD
Itraconazole—Urinary tract disorder—Methotrexate—muscle cancer	0.000277	0.00149	CcSEcCtD
Itraconazole—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000277	0.00149	CcSEcCtD
Itraconazole—Urethral disorder—Methotrexate—muscle cancer	0.000275	0.00148	CcSEcCtD
Itraconazole—Weight decreased—Doxorubicin—muscle cancer	0.000275	0.00148	CcSEcCtD
Itraconazole—Feeling abnormal—Etoposide—muscle cancer	0.000275	0.00147	CcSEcCtD
Itraconazole—Hyperglycaemia—Doxorubicin—muscle cancer	0.000274	0.00147	CcSEcCtD
Itraconazole—Nausea—Dactinomycin—muscle cancer	0.000273	0.00147	CcSEcCtD
Itraconazole—Pneumonia—Doxorubicin—muscle cancer	0.000273	0.00146	CcSEcCtD
Itraconazole—Gastrointestinal pain—Etoposide—muscle cancer	0.000272	0.00146	CcSEcCtD
Itraconazole—Dizziness—Vincristine—muscle cancer	0.000272	0.00146	CcSEcCtD
Itraconazole—Infestation NOS—Doxorubicin—muscle cancer	0.000271	0.00145	CcSEcCtD
Itraconazole—Infestation—Doxorubicin—muscle cancer	0.000271	0.00145	CcSEcCtD
Itraconazole—Drowsiness—Doxorubicin—muscle cancer	0.000271	0.00145	CcSEcCtD
Itraconazole—Visual impairment—Methotrexate—muscle cancer	0.000271	0.00145	CcSEcCtD
Itraconazole—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000269	0.00144	CcSEcCtD
Itraconazole—Renal failure—Doxorubicin—muscle cancer	0.000266	0.00143	CcSEcCtD
Itraconazole—Erythema multiforme—Methotrexate—muscle cancer	0.000266	0.00143	CcSEcCtD
Itraconazole—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000266	0.00143	CcSEcCtD
Itraconazole—Urticaria—Etoposide—muscle cancer	0.000265	0.00142	CcSEcCtD
Itraconazole—Jaundice—Doxorubicin—muscle cancer	0.000264	0.00142	CcSEcCtD
Itraconazole—Abdominal pain—Etoposide—muscle cancer	0.000263	0.00141	CcSEcCtD
Itraconazole—Body temperature increased—Etoposide—muscle cancer	0.000263	0.00141	CcSEcCtD
Itraconazole—Urinary tract infection—Doxorubicin—muscle cancer	0.000263	0.00141	CcSEcCtD
Itraconazole—Eye disorder—Methotrexate—muscle cancer	0.000263	0.00141	CcSEcCtD
Itraconazole—Tinnitus—Methotrexate—muscle cancer	0.000262	0.00141	CcSEcCtD
Itraconazole—Vomiting—Vincristine—muscle cancer	0.000262	0.0014	CcSEcCtD
Itraconazole—Cardiac disorder—Methotrexate—muscle cancer	0.000261	0.0014	CcSEcCtD
Itraconazole—Rash—Vincristine—muscle cancer	0.000259	0.00139	CcSEcCtD
Itraconazole—Dermatitis—Vincristine—muscle cancer	0.000259	0.00139	CcSEcCtD
Itraconazole—Haematuria—Doxorubicin—muscle cancer	0.000258	0.00139	CcSEcCtD
Itraconazole—Headache—Vincristine—muscle cancer	0.000258	0.00138	CcSEcCtD
Itraconazole—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000256	0.00138	CcSEcCtD
Itraconazole—Angiopathy—Methotrexate—muscle cancer	0.000255	0.00137	CcSEcCtD
Itraconazole—Sinusitis—Doxorubicin—muscle cancer	0.000254	0.00136	CcSEcCtD
Itraconazole—Immune system disorder—Methotrexate—muscle cancer	0.000254	0.00136	CcSEcCtD
Itraconazole—Mediastinal disorder—Methotrexate—muscle cancer	0.000253	0.00136	CcSEcCtD
Itraconazole—Agranulocytosis—Doxorubicin—muscle cancer	0.000253	0.00136	CcSEcCtD
Itraconazole—Chills—Methotrexate—muscle cancer	0.000252	0.00135	CcSEcCtD
Itraconazole—Alopecia—Methotrexate—muscle cancer	0.000248	0.00133	CcSEcCtD
Itraconazole—Mental disorder—Methotrexate—muscle cancer	0.000246	0.00132	CcSEcCtD
Itraconazole—Hypersensitivity—Etoposide—muscle cancer	0.000245	0.00132	CcSEcCtD
Itraconazole—Malnutrition—Methotrexate—muscle cancer	0.000245	0.00131	CcSEcCtD
Itraconazole—Nausea—Vincristine—muscle cancer	0.000244	0.00131	CcSEcCtD
Itraconazole—Rhinitis—Doxorubicin—muscle cancer	0.000244	0.00131	CcSEcCtD
Itraconazole—Hepatitis—Doxorubicin—muscle cancer	0.000243	0.00131	CcSEcCtD
Itraconazole—Hypoaesthesia—Doxorubicin—muscle cancer	0.000242	0.0013	CcSEcCtD
Itraconazole—Pharyngitis—Doxorubicin—muscle cancer	0.000241	0.0013	CcSEcCtD
Itraconazole—Urinary tract disorder—Doxorubicin—muscle cancer	0.00024	0.00129	CcSEcCtD
Itraconazole—Oedema peripheral—Doxorubicin—muscle cancer	0.00024	0.00129	CcSEcCtD
Itraconazole—Dysgeusia—Methotrexate—muscle cancer	0.000239	0.00129	CcSEcCtD
Itraconazole—Asthenia—Etoposide—muscle cancer	0.000239	0.00128	CcSEcCtD
Itraconazole—Connective tissue disorder—Doxorubicin—muscle cancer	0.000239	0.00128	CcSEcCtD
Itraconazole—Urethral disorder—Doxorubicin—muscle cancer	0.000238	0.00128	CcSEcCtD
Itraconazole—Back pain—Methotrexate—muscle cancer	0.000237	0.00127	CcSEcCtD
Itraconazole—Pruritus—Etoposide—muscle cancer	0.000236	0.00127	CcSEcCtD
Itraconazole—Visual impairment—Doxorubicin—muscle cancer	0.000234	0.00126	CcSEcCtD
Itraconazole—Vision blurred—Methotrexate—muscle cancer	0.00023	0.00124	CcSEcCtD
Itraconazole—Erythema multiforme—Doxorubicin—muscle cancer	0.00023	0.00123	CcSEcCtD
Itraconazole—Diarrhoea—Etoposide—muscle cancer	0.000228	0.00122	CcSEcCtD
Itraconazole—Eye disorder—Doxorubicin—muscle cancer	0.000227	0.00122	CcSEcCtD
Itraconazole—Ill-defined disorder—Methotrexate—muscle cancer	0.000227	0.00122	CcSEcCtD
Itraconazole—Tinnitus—Doxorubicin—muscle cancer	0.000227	0.00122	CcSEcCtD
Itraconazole—Cardiac disorder—Doxorubicin—muscle cancer	0.000226	0.00121	CcSEcCtD
Itraconazole—Angiopathy—Doxorubicin—muscle cancer	0.000221	0.00118	CcSEcCtD
Itraconazole—Malaise—Methotrexate—muscle cancer	0.000221	0.00118	CcSEcCtD
Itraconazole—Dizziness—Etoposide—muscle cancer	0.00022	0.00118	CcSEcCtD
Itraconazole—Immune system disorder—Doxorubicin—muscle cancer	0.00022	0.00118	CcSEcCtD
Itraconazole—Vertigo—Methotrexate—muscle cancer	0.00022	0.00118	CcSEcCtD
Itraconazole—Mediastinal disorder—Doxorubicin—muscle cancer	0.000219	0.00118	CcSEcCtD
Itraconazole—Leukopenia—Methotrexate—muscle cancer	0.000219	0.00117	CcSEcCtD
Itraconazole—Chills—Doxorubicin—muscle cancer	0.000218	0.00117	CcSEcCtD
Itraconazole—Arrhythmia—Doxorubicin—muscle cancer	0.000217	0.00117	CcSEcCtD
Itraconazole—Alopecia—Doxorubicin—muscle cancer	0.000215	0.00115	CcSEcCtD
Itraconazole—Cough—Methotrexate—muscle cancer	0.000213	0.00115	CcSEcCtD
Itraconazole—Mental disorder—Doxorubicin—muscle cancer	0.000213	0.00114	CcSEcCtD
Itraconazole—Vomiting—Etoposide—muscle cancer	0.000212	0.00114	CcSEcCtD
Itraconazole—Malnutrition—Doxorubicin—muscle cancer	0.000212	0.00114	CcSEcCtD
Itraconazole—Rash—Etoposide—muscle cancer	0.00021	0.00113	CcSEcCtD
Itraconazole—Dermatitis—Etoposide—muscle cancer	0.00021	0.00113	CcSEcCtD
Itraconazole—Headache—Etoposide—muscle cancer	0.000209	0.00112	CcSEcCtD
Itraconazole—Flatulence—Doxorubicin—muscle cancer	0.000209	0.00112	CcSEcCtD
Itraconazole—Arthralgia—Methotrexate—muscle cancer	0.000208	0.00112	CcSEcCtD
Itraconazole—Chest pain—Methotrexate—muscle cancer	0.000208	0.00112	CcSEcCtD
Itraconazole—Myalgia—Methotrexate—muscle cancer	0.000208	0.00112	CcSEcCtD
Itraconazole—Dysgeusia—Doxorubicin—muscle cancer	0.000207	0.00111	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000207	0.00111	CcSEcCtD
Itraconazole—Discomfort—Methotrexate—muscle cancer	0.000206	0.0011	CcSEcCtD
Itraconazole—Back pain—Doxorubicin—muscle cancer	0.000205	0.0011	CcSEcCtD
Itraconazole—Confusional state—Methotrexate—muscle cancer	0.000201	0.00108	CcSEcCtD
Itraconazole—Anaphylactic shock—Methotrexate—muscle cancer	0.0002	0.00107	CcSEcCtD
Itraconazole—Vision blurred—Doxorubicin—muscle cancer	0.0002	0.00107	CcSEcCtD
Itraconazole—Infection—Methotrexate—muscle cancer	0.000198	0.00106	CcSEcCtD
Itraconazole—Nausea—Etoposide—muscle cancer	0.000198	0.00106	CcSEcCtD
Itraconazole—Ill-defined disorder—Doxorubicin—muscle cancer	0.000196	0.00105	CcSEcCtD
Itraconazole—Nervous system disorder—Methotrexate—muscle cancer	0.000196	0.00105	CcSEcCtD
Itraconazole—Thrombocytopenia—Methotrexate—muscle cancer	0.000195	0.00105	CcSEcCtD
Itraconazole—Skin disorder—Methotrexate—muscle cancer	0.000194	0.00104	CcSEcCtD
Itraconazole—Hyperhidrosis—Methotrexate—muscle cancer	0.000193	0.00104	CcSEcCtD
Itraconazole—Malaise—Doxorubicin—muscle cancer	0.000191	0.00102	CcSEcCtD
Itraconazole—Vertigo—Doxorubicin—muscle cancer	0.00019	0.00102	CcSEcCtD
Itraconazole—Anorexia—Methotrexate—muscle cancer	0.00019	0.00102	CcSEcCtD
Itraconazole—Syncope—Doxorubicin—muscle cancer	0.00019	0.00102	CcSEcCtD
Itraconazole—Leukopenia—Doxorubicin—muscle cancer	0.00019	0.00102	CcSEcCtD
Itraconazole—Hypotension—Methotrexate—muscle cancer	0.000186	0.001	CcSEcCtD
Itraconazole—Loss of consciousness—Doxorubicin—muscle cancer	0.000186	0.000999	CcSEcCtD
Itraconazole—Cough—Doxorubicin—muscle cancer	0.000185	0.000992	CcSEcCtD
Itraconazole—Hypertension—Doxorubicin—muscle cancer	0.000183	0.000981	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000182	0.000976	CcSEcCtD
Itraconazole—Insomnia—Methotrexate—muscle cancer	0.000181	0.000969	CcSEcCtD
Itraconazole—Myalgia—Doxorubicin—muscle cancer	0.00018	0.000967	CcSEcCtD
Itraconazole—Chest pain—Doxorubicin—muscle cancer	0.00018	0.000967	CcSEcCtD
Itraconazole—Arthralgia—Doxorubicin—muscle cancer	0.00018	0.000967	CcSEcCtD
Itraconazole—Anxiety—Doxorubicin—muscle cancer	0.00018	0.000964	CcSEcCtD
Itraconazole—Paraesthesia—Methotrexate—muscle cancer	0.000179	0.000962	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000179	0.000961	CcSEcCtD
Itraconazole—Discomfort—Doxorubicin—muscle cancer	0.000178	0.000956	CcSEcCtD
Itraconazole—Dyspnoea—Methotrexate—muscle cancer	0.000178	0.000955	CcSEcCtD
Itraconazole—Somnolence—Methotrexate—muscle cancer	0.000177	0.000952	CcSEcCtD
Itraconazole—Dyspepsia—Methotrexate—muscle cancer	0.000176	0.000943	CcSEcCtD
Itraconazole—Confusional state—Doxorubicin—muscle cancer	0.000174	0.000935	CcSEcCtD
Itraconazole—Decreased appetite—Methotrexate—muscle cancer	0.000173	0.000931	CcSEcCtD
Itraconazole—Oedema—Doxorubicin—muscle cancer	0.000173	0.000927	CcSEcCtD
Itraconazole—Anaphylactic shock—Doxorubicin—muscle cancer	0.000173	0.000927	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000172	0.000925	CcSEcCtD
Itraconazole—Fatigue—Methotrexate—muscle cancer	0.000172	0.000923	CcSEcCtD
Itraconazole—Infection—Doxorubicin—muscle cancer	0.000172	0.000921	CcSEcCtD
Itraconazole—Pain—Methotrexate—muscle cancer	0.000171	0.000916	CcSEcCtD
Itraconazole—Shock—Doxorubicin—muscle cancer	0.00017	0.000912	CcSEcCtD
Itraconazole—Nervous system disorder—Doxorubicin—muscle cancer	0.000169	0.000909	CcSEcCtD
Itraconazole—Thrombocytopenia—Doxorubicin—muscle cancer	0.000169	0.000908	CcSEcCtD
Itraconazole—Tachycardia—Doxorubicin—muscle cancer	0.000169	0.000905	CcSEcCtD
Itraconazole—Skin disorder—Doxorubicin—muscle cancer	0.000168	0.000901	CcSEcCtD
Itraconazole—Hyperhidrosis—Doxorubicin—muscle cancer	0.000167	0.000897	CcSEcCtD
Itraconazole—Anorexia—Doxorubicin—muscle cancer	0.000165	0.000884	CcSEcCtD
Itraconazole—Feeling abnormal—Methotrexate—muscle cancer	0.000164	0.000883	CcSEcCtD
Itraconazole—Gastrointestinal pain—Methotrexate—muscle cancer	0.000163	0.000876	CcSEcCtD
Itraconazole—Hypotension—Doxorubicin—muscle cancer	0.000161	0.000867	CcSEcCtD
Itraconazole—Urticaria—Methotrexate—muscle cancer	0.000159	0.000851	CcSEcCtD
Itraconazole—Body temperature increased—Methotrexate—muscle cancer	0.000158	0.000847	CcSEcCtD
Itraconazole—Abdominal pain—Methotrexate—muscle cancer	0.000158	0.000847	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000157	0.000845	CcSEcCtD
Itraconazole—Insomnia—Doxorubicin—muscle cancer	0.000156	0.000839	CcSEcCtD
Itraconazole—Paraesthesia—Doxorubicin—muscle cancer	0.000155	0.000833	CcSEcCtD
Itraconazole—Dyspnoea—Doxorubicin—muscle cancer	0.000154	0.000827	CcSEcCtD
Itraconazole—Somnolence—Doxorubicin—muscle cancer	0.000154	0.000824	CcSEcCtD
Itraconazole—Dyspepsia—Doxorubicin—muscle cancer	0.000152	0.000816	CcSEcCtD
Itraconazole—Decreased appetite—Doxorubicin—muscle cancer	0.00015	0.000806	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000149	0.000801	CcSEcCtD
Itraconazole—Fatigue—Doxorubicin—muscle cancer	0.000149	0.0008	CcSEcCtD
Itraconazole—Pain—Doxorubicin—muscle cancer	0.000148	0.000793	CcSEcCtD
Itraconazole—Constipation—Doxorubicin—muscle cancer	0.000148	0.000793	CcSEcCtD
Itraconazole—Hypersensitivity—Methotrexate—muscle cancer	0.000147	0.000789	CcSEcCtD
Itraconazole—Asthenia—Methotrexate—muscle cancer	0.000143	0.000768	CcSEcCtD
Itraconazole—Feeling abnormal—Doxorubicin—muscle cancer	0.000142	0.000764	CcSEcCtD
Itraconazole—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000141	0.000758	CcSEcCtD
Itraconazole—Pruritus—Methotrexate—muscle cancer	0.000141	0.000758	CcSEcCtD
Itraconazole—Urticaria—Doxorubicin—muscle cancer	0.000137	0.000737	CcSEcCtD
Itraconazole—Abdominal pain—Doxorubicin—muscle cancer	0.000137	0.000733	CcSEcCtD
Itraconazole—Body temperature increased—Doxorubicin—muscle cancer	0.000137	0.000733	CcSEcCtD
Itraconazole—Diarrhoea—Methotrexate—muscle cancer	0.000137	0.000733	CcSEcCtD
Itraconazole—Dizziness—Methotrexate—muscle cancer	0.000132	0.000708	CcSEcCtD
Itraconazole—Hypersensitivity—Doxorubicin—muscle cancer	0.000127	0.000683	CcSEcCtD
Itraconazole—Vomiting—Methotrexate—muscle cancer	0.000127	0.000681	CcSEcCtD
Itraconazole—Rash—Methotrexate—muscle cancer	0.000126	0.000675	CcSEcCtD
Itraconazole—Dermatitis—Methotrexate—muscle cancer	0.000126	0.000675	CcSEcCtD
Itraconazole—Headache—Methotrexate—muscle cancer	0.000125	0.000671	CcSEcCtD
Itraconazole—Asthenia—Doxorubicin—muscle cancer	0.000124	0.000665	CcSEcCtD
Itraconazole—Pruritus—Doxorubicin—muscle cancer	0.000122	0.000656	CcSEcCtD
Itraconazole—Nausea—Methotrexate—muscle cancer	0.000119	0.000636	CcSEcCtD
Itraconazole—Diarrhoea—Doxorubicin—muscle cancer	0.000118	0.000635	CcSEcCtD
Itraconazole—Dizziness—Doxorubicin—muscle cancer	0.000114	0.000613	CcSEcCtD
Itraconazole—Vomiting—Doxorubicin—muscle cancer	0.00011	0.00059	CcSEcCtD
Itraconazole—Rash—Doxorubicin—muscle cancer	0.000109	0.000585	CcSEcCtD
Itraconazole—Dermatitis—Doxorubicin—muscle cancer	0.000109	0.000584	CcSEcCtD
Itraconazole—Headache—Doxorubicin—muscle cancer	0.000108	0.000581	CcSEcCtD
Itraconazole—Nausea—Doxorubicin—muscle cancer	0.000103	0.000551	CcSEcCtD
